INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

SARASOTA, Fla., Aug. 28, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, taking place September 14 through September 16, 2026, at the Lotte New York Palace Hotel in New York City.

A pre-recorded presentation from the Company will be available on demand as a part of the conference beginning Friday, September 11, 2026, at 7:00 a.m. ET. A copy of the slide presentation is available on the investor relations portion of the INVO Fertility website at https://invofertility.com/investors/events-presentations/.